Stocks Health care DRUG
NASDAQ · Health careBright Minds Biosciences Inc. (DRUG)
It posted a net loss of CA$2.8M. At September 30, 2024 it held CA$5.7M in cash. Its latest periodic report to the SEC is the annual report (Canadian issuer) (40-F) filed on December 23, 2025.
What Bright Minds Biosciences Inc. does
Bright Minds Biosciences Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker DRUG.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2024 | n/a | -CA$2.8M | -CA$0.65 | n/a |
| 2023 | n/a | -CA$7.4M | -CA$1.98 | n/a |
| 2022 | n/a | -CA$15M | -CA$6.06 | n/a |
| 2021 | n/a | -CA$8.7M | -CA$4.82 | n/a |
| 2021 | n/a | -CA$480.4K | -CA$0.65 | n/a |
Latest SEC filings
What Bright Minds Biosciences Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 17, 2026
- August 14, 2026Passive stake changed SCHEDULE 13G/A
- August 13, 2026
- August 12, 2026Passive stake changed SCHEDULE 13G/A
- July 2, 2026Activist stake changed SCHEDULE 13D/A
- June 3, 2026
- June 2, 2026
- May 28, 2026
- May 20, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
Questions about DRUG
What does Bright Minds Biosciences Inc. do?
Bright Minds Biosciences Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker DRUG.
Is Bright Minds Biosciences Inc. profitable?
No. In fiscal 2024 it reported a net loss of CA$2.8M.
When did Bright Minds Biosciences Inc. last report?
Its most recent periodic report is the annual report (Canadian issuer) (40-F) filed on December 23, 2025. It covers the period to September 30, 2025. Its newest filing of any kind is the foreign issuer update from August 17, 2026.
Similar companies
Follow DRUG
Get an email when Bright Minds Biosciences Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow DRUG: get an email when it filesWhere the numbers come from
Financial figures are the values Bright Minds Biosciences Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.